Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome.
about
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessmentSarcoidosis and Antiphospholipid Syndrome: A Systematic Review of CasesPredictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis.Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.Lupus nephritis: current issues.Reviewing the recommendations for lupus in children.Organ Damage and Quality of Life in Antiphospholipid Syndrome.Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS).Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.
P2860
Q24675466-0E2F095A-5AA6-4AF7-9A79-B27FAD9DC8B2Q26775647-3C818C21-7A34-43F5-9116-D8E9E10E0174Q30956012-9F97B3B8-033E-4EC1-9C6B-8C348C93DAA7Q33374901-F3D8A81E-7F1F-4ACA-B6BF-3531F6B42183Q34331685-32F9F600-2AB6-42F1-A7EB-8A0EBA25E890Q35553102-300A56E4-4F0E-4884-AB12-D7E269A8E188Q38374309-94E68131-A96A-47BC-BAAC-A1B164065084Q38697342-3C9BA451-A5D5-44DA-9AE5-DF1B9995631EQ41939439-D5865D54-E73D-41C0-8841-6451F8E92D22Q43537426-AC75EC90-7876-43E8-9BA3-6EF001B85326Q45034886-423B25C1-4272-4A21-9DDE-43E04AFDD61AQ48046065-1DFC6464-4CF3-4269-BD5D-36058218FC5EQ50785654-F253847B-4A80-45F7-9DD8-7DF696C8EB16
P2860
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@ast
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@en
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@nl
type
label
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@ast
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@en
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@nl
prefLabel
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@ast
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@en
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@nl
P2093
P356
P1476
Prognostic factors and cluster ...... in antiphospholipid syndrome.
@en
P2093
Ioannidis JP
Moutsopoulos HM
Tektonidou MG
Vlachoyiannopoulos PG
P304
P356
10.1093/QJMED/93.8.523
P407
P577
2000-08-01T00:00:00Z